- Home
- / Recipharm Stockholm
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Recipharm Stockholm financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
KR219.5 M
FY, 2020
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| SEK | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|
| Revenue | 240.0M | 261.9M | 219.5M |
| Cost of goods sold | 145.4M | 156.2M | 145.8M |
| Gross profit | 94.6M | 105.7M | 73.8M |
| Gross profit margin, % | 39.4% | 40.4% | 33.6% |
| General and administrative expense | 119.8M | 111.6M | 50.6M |
| Operating expense total | 120.6M | 113.8M | 51.2M |
| Depreciation and amortization | 1.5M | ||
| EBIT | (20.3M) | 656.9K | 34.6M |
| EBIT margin, % | -8.4% | 0.3% | 15.8% |
| Interest income | 157.1K | 2.7M | 7.7M |
| Interest expense | 3.9M | 9.0M | 10.2M |
| Pre tax profit | 15.0M | (690.4K) | (864.4K) |
| Income tax expense | 4.9M | ||
| Net Income | 10.1M | (690.4K) | (864.4K) |